About 100 attending physicians were employed directly by Philadelphia Academic Health System, (PAHS), which bought Hahnemann in January 2018 and filed for chapter 11 bankruptcy in June 2019, whyy.org reported. All the residents and fellows were also employed by PAHS.
The attending doctors were notified in August that they would not be receiving continued malpractice insurance from their former employer. Now, the more than 550 residents and fellows are worried they won’t get that coverage either. The order authorizing the $55 million sale of Hahnemann’s residency program in bankruptcy court would have guaranteed the money to pay for their continued malpractice coverage, but with that case tied up in court, it’s not clear where the funds would come from. With the sale looking increasingly like a long-shot, many, including former residency program officials and professional organizations, worry the coverage will never come through. Hahnemann’s former internal medical residency program director David Aizenberg is preparing his former residents to buy it on their own.
“I foresee this to be a significant challenge for them to afford individually,” Aizenberg said, “if not impossible.”
